Welcome to our dedicated page for Cycurion SEC filings (Ticker: CYCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cycurion, Inc. (NASDAQ: CYCU) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports, registration statements, and other documents filed with the U.S. Securities and Exchange Commission. As an emerging growth company based in McLean, Virginia, Cycurion uses these filings to report on its AI-driven cybersecurity and public-sector technology business, capital structure changes, and material events.
Current reports on Form 8-K document key developments such as private placements, special share dividends, reverse stock splits, contract awards, financial results, and listing status updates. For example, recent 8-K filings describe a one-for-thirty reverse stock split, a special dividend of CYCU common shares valued at $500,000 and subsequent adjustments to the distribution ratio, contracts awarded to subsidiaries like SLG Innovation, Inc., and a determination by Nasdaq that Cycurion regained compliance with minimum bid price requirements.
Registration statements on Form S-1 and S-1/A outline Cycurion’s plans to offer securities and provide detailed information about the company, its business, and its financial statements. These filings are central for understanding the company’s capital-raising activities and its status as an emerging growth company.
Investors and analysts can also use Cycurion’s SEC filings to track warrant terms, reverse stock split mechanics, insider trading policies, and contract disclosures referenced in attached exhibits. Stock Titan’s platform surfaces these documents alongside AI-powered summaries that explain the significance of filings, helping readers quickly interpret complex legal and financial language.
Through this page, users can monitor Cycurion’s ongoing reporting obligations, including quarterly and annual reports when filed, as well as additional 8-Ks covering cybersecurity initiatives, government contracts, and governance changes. Real-time updates from EDGAR combined with AI-generated highlights make it easier to follow how regulatory filings reflect Cycurion’s evolving AI cybersecurity and public-sector IT strategy.
Cycurion, Inc. approved and implemented a 1-for-30 reverse stock split of its common stock. The action becomes effective with the commencement of business on October 27, 2025, and the shares will begin trading on a split-adjusted basis on The Nasdaq Global Market under the symbol CYCU.
Every thirty issued shares will be combined into one share without changing the par value or the total number of authorized common shares. The number of outstanding common shares will be reduced from approximately 86,533,435 to approximately 2,884,447. No fractional shares will be issued; holders entitled to a fraction will receive a cash payment based on the closing price on the trading day immediately preceding the effective date. Proportionate adjustments will be made to outstanding warrants, option exercise prices and share amounts, and restricted stock awards. The new CUSIP for the common stock will be 95758L305.
Cycurion, Inc. (CYCU) reported a Nasdaq delisting determination and filed an appeal. The company received notice on October 14, 2025 that its common stock is subject to delisting from the Nasdaq Global Market after failing to regain compliance with the $1.00 bid price rule. Cycurion submitted an appeal on October 20, 2025, which stays any suspension and Form 25-NSE filing pending a panel decision, with hearings typically set 30–45 days after the request.
To address the bid-price deficiency, the board approved a 30:1 reverse stock split expected to take effect on October 27, 2025, following prior stockholder approval of a reverse-split range. The company also announced five new contracts totaling approximately $1 million, expected to add $75,000 in monthly recurring revenue. If the appeal is unsuccessful, the shares may move to the over-the-counter market, which the company notes is a more limited and less liquid trading venue and could pressure the stock price.
Cycurion, Inc. reported that its board of directors has waived the lock-up restrictions on its Series A Convertible Preferred Stock. These preferred shares, and the securities issuable upon conversion, had been subject to a one-year lock-up starting from the February 14, 2025 closing of the business combination with Western Acquisition Ventures Corp.
The original terms allowed an early release after six months only if the daily trading value of Cycurion common stock exceeded $150,000 for 30 consecutive trading days and the 30-day volume-weighted average price was above $5.00. Because these trading conditions have not been met, the lock-up would have otherwise remained in place.
The board determined it was in the company’s best interests to waive the restrictions because the Series A Convertible Preferred Stock accrues approximately $120,000 per year in stock or cash payments. If holders convert their preferred shares into common stock, Cycurion could avoid about $120,000 in annual costs, which the company describes as part of a strategic recapitalization to strengthen its balance sheet and support growth initiatives.